Specific weight loss medications may also benefit ocular outcomes
Research

Specific weight loss medications may also benefit ocular outcomes

Newer anti-obesity medications demonstrate a superior ocular safety profile to traditional agents.
VIZZ presbyopia eye drops launch in the US
Products

VIZZ presbyopia eye drops launch in the US

Commercial rollout of first-ever aceclidine-based eye drop for presbyopia expected to begin this month, with broader availability later in Q4 2025.
Harrow to purchase Melt Pharmaceuticals
Business

Harrow to purchase Melt Pharmaceuticals

Key draw is the company’s patented oral tablet formulated for a sublingual delivery to provide rapid sedation and analgesia ahead of cataract surgery.
GMAC launches free myopia awareness toolkit for ECPs
Events

GMAC launches free myopia awareness toolkit for ECPs

Downloadable resources include take-home brochures, social media graphics, and more to raise awareness and education of pediatric disease progression.
CMS assigns permanent J-code for Neurotech's ENCELTO cell therapy
Products

CMS assigns permanent J-code for Neurotech's ENCELTO cell therapy

The allogeneic encapsulated cell-based therapy is the first and only treatment approved by the FDA for the treatment of MacTel.
National trial to test preventative atropine drops for pediatric myopia
Research

National trial to test preventative atropine drops for pediatric myopia

The University of Houston and The Ohio State University researchers partner on NEI-funded study to test if low-concentrated drops delay onset of myopia.
Are corneal dystrophies linked to mental health conditions?
Research

Are corneal dystrophies linked to mental health conditions?

Study highlights the importance of assessing corneal dystrophy patients’ psychological well-being.
FDA authorizes marketing of Essilor Stellest eyeglass lenses for myopia
Products

FDA authorizes marketing of Essilor Stellest eyeglass lenses for myopia

The first eyeglass lenses authorized for marketing to slow the progression of pediatric myopia will be available in the U.S. in the coming weeks.
Leadership update: SpyGlass, Lumata Health, and Horizon Surgical report changes
Business

Leadership update: SpyGlass, Lumata Health, and Horizon Surgical report changes

Latest news from the eyecare space includes a new VP at SpyGlass ahead of phase 3 trials on its glaucoma drug delivery platform.
Could the retina help detect early hearing loss?
Research

Could the retina help detect early hearing loss?

Study highlights utility of retinal microvascular parameters to detect early signs of hearing loss.
Virtual Field launches connectivity hub for instant VF-EHR integration
Products

Virtual Field launches connectivity hub for instant VF-EHR integration

VR-based VF device developer introduces new DICOM 360 Sync, designed to automatically synchronize and integrate imaging data rapidly in real-time.
Registration open for Eyes On 2026
Events

Registration open for Eyes On 2026

Taking place Nov. 14-15, the largest virtual eyecare event of the year offers up to 7.5 credits of CE with clinician-led sessions from leading MDs and ODs.
FDA approves Amneal's bimatoprost 0.01% generic
Products

FDA approves Amneal's bimatoprost 0.01% generic

Generic version of Allergan’s LUMIGAN is indicated for reducing elevated IOP in glaucoma and ocular hypertensive patients.
Ollin Biosciences debuts with next-gen ophthalmic pipeline
Business

Ollin Biosciences debuts with next-gen ophthalmic pipeline

Biotech launches with $100 million financing and a lead program addressing wet AMD and DME via a higher potency VEGF/Ang2 bispecific antibody.
Researchers uncover new muscular data to target eyelid and blinking rates
Research

Researchers uncover new muscular data to target eyelid and blinking rates

Study highlights neuromuscular complexity of eyelid motion and roadmap for new diagnostic tools and therapies.
EyeMD EMR rebrands as Optivate with expanded vision
Business

EyeMD EMR rebrands as Optivate with expanded vision

Clinical software solutions company initiates months-long transition in its ophthalmology practice services, with completion date set for end of 2025.
FDA grants priority review for Chiesi's LHON therapeutic
Pipeline

FDA grants priority review for Chiesi's LHON therapeutic

Approved by the EMA as Raxone, idebenone could become the first and only clinically proven treatment to address the underlying cause of LHON.
Eyexora launches with focus on accelerated ophthalmic asset development
Business

Eyexora launches with focus on accelerated ophthalmic asset development

First ‘hub-and-spoke’ model ophthalmology company is targeting a global portfolio of anterior and posterior segment therapeutics and medical devi
Topcon launches dry eye imager with robotic intelligence
Products

Topcon launches dry eye imager with robotic intelligence

TERA is a multimodal platform for detecting, grading, and managing DED—and pairs robotic automation with high-res imaging for standardized testing.
Olleyes launches VR-based hearing platform for ECPs
Products

Olleyes launches VR-based hearing platform for ECPs

Developer of the VisuALL VRP adds HearALL screening test to its offerings, enabling comprehensive hearing assessments during eye exams.